Life Sciences

Framingham biotech company SCIEX announced a supply relationship with RedShiftBio, a Burlington firm specializing in analytical instrumentation for therapeutic drugs.

The 9/90 Corporate Center, a four-building office and lab campus in Framingham, sold for $93 million in a multi-property deal closed on Wednesday, Newmark Group, Inc., who brokered the deal, announced.

The number of women sitting on Massachusetts biopharmaceutical company boards has increased 164% since 2017, according to a new report from a voluntary survey conducted by industry group MassBio released Wednesday.

Construction of a 120,600-square-foot biotech facility has been approved by the City of Marlborough, according to Lincoln Property Co., a real estate developer based in Texas with offices in Boston.

Marlborough medical device manufacturer Hologic, Inc., earned profits of $329 million in the fourth quarter, a 34% decrease from the fourth quarter 2020's profits of $494 million, according to the company's earnings report.

The former Allegro MicroSystems building at 115 Northeast Cutoff in Worcester has been rebranded as I-290Connector, as Worcester-based developer Chacharone Properties renovates the 130,000-square-foot former Allegro building into flex/lab space.

Quinsigamond Community College in Worcester is partnering with Worcester incubator Massachusetts Biomedical Initiatives and biopharmaceutical company AbbVie, which has an outpost in the city, to pilot an entry-level Biomanufacturing On-Ramp Workshop intended to help encourage participants to entry the biomanufacturing industry pipeline.

Marlborough medical device manufacturer Boston Scientific Corp. released its third quarter earnings report on Wednesday, which revealed a profits of $419 million.

NorthBridge Partners, LLC, a real estate investment company based in Wakefield, has purchased $16.2 million in properties in Shrewsbury, Sterling, and Boylston over the last few weeks.

Pillar Biosciences Inc. of Natick announced Thursday a partnership with North Carolina-based Labcorp to provide genomic testing for people with cancer.